Searched over 200M research papers for "atenolol 100mg"
10 papers analyzed
These studies suggest atenolol 100mg is effective for hypertension, angina pectoris, and chronic ventricular arrhythmias, but offers no significant advantage over a 50mg dose for hypertension.
20 papers analyzed
Atenolol, a cardioselective beta-blocker, is widely used in the management of hypertension. Studies have shown that a daily dose of 100mg atenolol effectively reduces both systolic and diastolic blood pressure in patients with mild to moderate hypertension. In a comparative study, 61% of patients responded positively to atenolol, showing a significant reduction in diastolic blood pressure compared to pindolol. Another study confirmed that atenolol 100mg provides 24-hour blood pressure control due to its long biological action, with a mean elimination half-life of approximately 10 hours.
When compared to other beta-blockers, atenolol 100mg has demonstrated similar or superior efficacy. For instance, in a study comparing atenolol with bisoprolol, both drugs showed comparable effectiveness in reducing angina attacks and improving exercise tolerance in patients with coronary artery disease. Additionally, atenolol was found to cause fewer respiratory side effects in asthmatic patients compared to propranolol and metoprolol, making it a preferable option when a beta-blocker is necessary for asthmatics.
Research indicates that there is no significant difference in blood pressure reduction between 50mg and 100mg doses of atenolol in patients with mild to moderate hypertension . This suggests that starting treatment with a lower dose may be equally effective and could potentially reduce the risk of side effects.
Atenolol is generally well-tolerated, with fewer side effects reported compared to other beta-blockers. Common side effects include fatigue, sleep disturbances, and muscle cramps, but these are less frequent than with pindolol. In terms of cardiovascular safety, atenolol has been shown to reduce platelet adhesion, which may contribute to its cardioprotective effects. However, it is important to monitor plasma cholesterol levels, as atenolol can reduce high-density lipoprotein cholesterol.
A bioequivalence study comparing two brands of atenolol 100mg tablets (Tensotin and Tenormin) found that both formulations are bioequivalent, with similar pharmacokinetic profiles. This ensures that patients can expect consistent therapeutic effects regardless of the brand.
Atenolol 100mg is an effective and well-tolerated option for the treatment of hypertension and angina pectoris. It offers comparable efficacy to other beta-blockers with a favorable side effect profile. While higher doses do not significantly enhance blood pressure control, they may be necessary for certain patients. Overall, atenolol remains a reliable choice in the management of cardiovascular conditions.
Most relevant research papers on this topic